Latest filing published 19 Aug 2026 for Structure Therapeutics Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Xichen Lin appears in our data through filings on Structure Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 15 March 2024 to 18 August 2026, the count stands at 13 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 19 August 2026, the filings show a transaction in Structure Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations